Publication | Closed Access

Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone

NeurophysiologyMedicineNeurotransmitterPsychopharmacologyNeuropharmacologyNeurologyNeuroscienceDopaminePharmacologyNeurochemistryBrain Extracellular DopamineSocial Sciences